1 |
Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia[J]. Hematology Am Soc Hematol Educ Program, 2013 (1): 76-81.
|
2 |
Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia[J]. Br J Haematol, 2016, 172 (2): 187-207.
|
3 |
Young NS. Aplastic Anemia[J]. N Engl J Med, 2018, 379 (17): 1643-1656.
|
4 |
Iftikhar R, Chaudhry QUN, Anwer F, et al. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies[J]. Blood Rev, 2021 (47): 100772.
|
5 |
沈娣,赵永强.血液病诊断及治疗标准[M]. 4版. 北京:科学出版社,2018:19-21.
|
6 |
National Cancer Institute, National Institutes of Health. Common terminology criteria for adverse events (CTCAE) version 4.0[EB/OL]. (2010-06-14)[2022-01-03].
URL
|
7 |
Schoemans HM, Lee SJ, Ferrara JL, et al. EBMT--NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment[J]. Bone Marrow Transplant, 2018, 53 (11): 1401-1415.
|
8 |
Mortensen BK, Jacobsen N, Heilmann C, et al. Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors[J]. Bone Marrow Transplant, 2016, 51 (2): 288-290.
|
9 |
Dufour C, Veys P, Carraro E, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT[J]. Br J Haematol, 2015, 171 (4): 585-594.
|
10 |
张颖.异基因造血干细胞移植治疗恶性血液病的临床研究[D].广州:南方医科大学,2019.
|
11 |
孙佳丽.异基因造血干细胞移植治疗老年恶性血液病疗效分析[D].北京:北京协和医学院,2014.
|
12 |
张樱.单倍体造血干细胞移植及同基因造血干细胞移植治疗再生障碍性贫血的临床研究[D].北京:中国医学科学院,2021.
|
13 |
黄晓军,韩伟,许兰平,等. HLA配型不合情况下造血干细胞移植的新方法[J].北京大学学报(医学版),2004,36(3):229-233.
|
14 |
张维婕,张书芹,费新红,等.旁系造血干细胞移植治疗急性白血病的临床分析[J].临床血液学杂志,2020,33(11):749-752,758.
|
15 |
Lu Y, Sun RJ, Zhao YL, et al. Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia[J]. Biol Blood Marrow Transplant, 2018, 24 (9): 1881-1887.
|
16 |
Yang S, Yuan X, Ma R, et al. Comparison of outcomes of frontline immunosuppressive therapy and frontline haploidentical hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched sibling donor[J]. Biol Blood Marrow Transplant, 2019, 25 (5): 975-980.
|
17 |
Al-Zahrani H, Nassar A, Al-Mohareb F, et al. Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia[J]. Biol Blood Marrow Transplant, 2011, 17 (5): 717-722
|
18 |
Ye BD, Zhang X, Shao KD, et al. Combined use of Chinese medicine with allogeneic hematopoietic stem cell transplantation for severe aplastic anemia patients[J]. Chin J Integr Med, 2014, 20 (12): 903-909.
|